☆ 4.6 Editorial Material

The link between type 2 diabetes and dementia: from biomarkers to treatment

LANCET DIABETES & ENDOCRINOLOGY (2020)

Journal

LANCET DIABETES & ENDOCRINOLOGY

Volume 8, Issue 9, Pages 736-738

Publisher

ELSEVIER SCIENCE INC

DOI: 10.1016/S2213-8587(20)30267-9

Keywords

-

Categories

Endocrinology & Metabolism

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Multidisciplinary Sciences

Opportunistic detection of type 2 diabetes using deep learning from frontal chest radiographs

Ayis Pyrros, Stephen M. M. Borstelmann, Ramana Mantravadi, Zachary Zaiman, Kaesha Thomas, Brandon Price, Eugene Greenstein, Nasir Siddiqui, Melinda Willis, Ihar Shulhan, John Hines-Shah, Jeanne M. M. Horowitz, Paul Nikolaidis, Matthew P. P. Lungren, Jorge Mario Rodriguez-Fernandez, Judy Wawira Gichoya, Sanmi Koyejo, Adam E. Flanders, Nishith Khandwala, Amit Gupta, John W. W. Garrett, Joseph Paul Cohen, Brian T. T. Layden, Perry J. J. Pickhardt, William Galanter

Summary: Traditional T2D screening methods rely on age, BMI guidelines, and glucose measurements. In this study, a deep learning model was used to screen for T2D using chest radiographs and electronic health record data, showing potential for early detection and intervention.

NATURE COMMUNICATIONS (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Exploring the link between Parkinson's disease and type 2 diabetes mellitus in Drosophila

Francisco Jose Sanz, Cristina Solana-Manrique, Joaquin Lilao-Garzon, Yeray Brito-Casillas, Silvia Munoz-Descalzo, Nuria Paricio

Summary: Recent studies have found a potential link between diabetes and Parkinson's disease. Using fruit fly and mouse models, as well as human neuron-like cells, researchers discovered that high glucose levels may contribute to the development of Parkinson's disease, and the anti-diabetic drug metformin could potentially be used as a treatment for the disease.

FASEB JOURNAL (2022)

Add to Collection

Article Multidisciplinary Sciences

Untangling the genetic link between type 1 and type 2 diabetes using functional genomics

Denis M. Nyaga, Mark H. Vickers, Craig Jefferies, Tayaza Fadason, Justin M. O'Sullivan

Summary: The study utilized an integrated functional genomics approach to analyze the genetic factors linking T1D and T2D, finding that certain genes may have dual impacts on the development of both diabetes types. Specifically, some genes regulate inflammatory and metabolic pathways, potentially affecting both diseases, but there was no significant genetic correlation between risk variants for T1D and T2D.

SCIENTIFIC REPORTS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Rethinking Fragility Fractures in Type 2 Diabetes: The Link between Hyperinsulinaemia and Osteofragilitas

Isabella D. Cooper, Kenneth H. Brookler, Catherine A. P. Crofts

Summary: Patients with T2DM and/or CVD have lower levels of osteocalcin and bone remodelling, leading to increased risk of fragility fractures. Hyperinsulinaemia in these patients is associated with normal to increased bone mineral density and higher risk of fragility fractures. Hyperinsulinaemia leads to decreased antioxidant activity and mitochondrial dysfunction, affecting osteoblast/cytogenesis and osteocyte viability.

BIOMEDICINES (2021)

Add to Collection

Review Biochemistry & Molecular Biology

A Growing Link between Circadian Rhythms, Type 2 Diabetes Mellitus and Alzheimer's Disease

Xuemin Peng, Rongping Fan, Lei Xie, Xiaoli Shi, Kun Dong, Shujun Zhang, Jing Tao, Weijie Xu, Delin Ma, Juan Chen, Yan Yang

Summary: T2DM patients are at higher risk of developing AD, and circadian rhythm disruption may contribute to both diseases. Promising therapeutic strategies for T2DM and AD include pharmacological and non-pharmacological treatments.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Oncology

Immunological link between periodontitis and type 2 diabetes deciphered by single-cell RNA analysis

Hansong Lee, Ji-Young Joo, Jae-Min Song, Hyun-Joo Kim, Yun Hak Kim, Hae Ryoun Park

Summary: Type 2 diabetes mellitus impairs the effector function and differentiation of T/NK cells. The RESISTIN pathway is a risk factor that makes periodontitis a precursor to type 2 diabetes mellitus.

CLINICAL AND TRANSLATIONAL MEDICINE (2023)

Add to Collection

Review Gastroenterology & Hepatology

The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments

Giovanni Targher, Kathleen E. Corey, Christopher D. Byrne, Michael Roden

Summary: Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) have a complex relationship with each other, influencing the risk of adverse clinical outcomes. The severity of NAFLD is directly related to the risk of developing T2DM, while improvement of NAFLD may lower the risk of T2DM.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Potential Biomarkers to Predict Acute Ischemic Stroke in Type 2 Diabetes

Abu Saleh Md Moin, Manjula Nandakumar, Ahmed Al-Qaissi, Thozhukat Sathyapalan, Stephen L. Atkin, Alexandra E. Butler

Summary: This study investigated several proteins indicative of acute ischemic stroke due to large vessel occlusion in patients with type 2 diabetes, finding that certain proteins were elevated in these patients, potentially indicating a higher risk of ischemic stroke.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Add to Collection

Article Clinical Neurology

Dementia risk in patients with type 2 diabetes: Comparing metformin with no pharmacological treatment

Bang Zheng, Bowen Su, Sara Ahmadi-Abhari, Dimitrios Kapogiannis, Ioanna Tzoulaki, Elio Riboli, Lefkos Middleton

Summary: A study conducted in the UK found that type 2 diabetes patients who were treated with metformin had a lower risk of dementia. The risk was even lower for patients who used metformin for a longer duration.

ALZHEIMERS & DEMENTIA (2023)

Add to Collection

Article Endocrinology & Metabolism

Identifying blood biomarkers for type 2 diabetes subtyping: a report from the ORIGIN trial

Marie Pigeyre, Hertzel Gerstein, Emma Ahlqvist, Sibylle Hess, Guillaume Pare

Summary: Individuals with diabetes can be classified into five subtypes based on clinical variables. This study identified 25 serum biomarkers that are independent determinants of type 2 diabetes subtypes. These biomarkers could be used for subtyping diagnosis of diabetes.

DIABETOLOGIA (2023)

Add to Collection

Review Endocrinology & Metabolism

Insulin-like Growth Factor 2 mRNA-Binding Protein 2-a Potential Link Between Type 2 Diabetes Mellitus and Cancer

Junguo Cao, Weijia Yan, Xiujian Ma, Haiyan Huang, Hong Yan

Summary: IGF2BP2 plays a crucial role in the pathogenesis of both T2DM and cancer by regulating glucose metabolism, insulin sensitivity, and tumorigenesis. Studies have shown that IGF2BP2 is involved in the increased risk of certain malignancies in T2DM patients and that single-nucleotide variations of IGF2BP2 are associated with both diseases.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Add to Collection

Review Endocrinology & Metabolism

New Horizons-Cognitive Dysfunction Associated With Type 2 Diabetes

Chris Moran, Stephanie Than, Michele Callisaya, Richard Beare, Velandai Srikanth

Summary: As the prevalence of type 2 diabetes (T2D) and cognitive dysfunction rises with age, clinicians are faced with managing older individuals with both conditions. The association between T2D and cognitive dysfunction has led to an increased interest in exploring the potential causal role of T2D in cognitive decline and dementia. Recent advancements in research methods allow for a better understanding of the mechanistic pathways involved in T2D-related cognitive dysfunction, guiding clinical recommendations.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Add to Collection

Review Neurosciences

Sleep Disturbances and Cognitive Impairment in the Course of Type 2 Diabetes-A Possible Link

Anna Brzecka, Natalia Madetko, Vladimir N. Nikolenko, Ghulam M. Ashraf, Maria Ejma, Jerzy Leszek, Cyryl Daroszewski, Karolina Sarul, Liudmila M. Mikhaleva, Siva G. Somasundaram, Cecil E. Kirkland, Sergey O. Bachurin, Gjumrakch Aliev

Summary: Both sleep disturbances and diabetes may lead to cognitive impairment, and they may independently lead to and/or mutually aggravate cognitive impairment.

CURRENT NEUROPHARMACOLOGY (2021)

Add to Collection

Article Cell Biology

Targeting Protein O-GlcNAcylation, a Link between Type 2 Diabetes Mellitus and Inflammatory Disease

Israel Olapeju Bolanle, Timothy M. Palmer

Summary: Unresolved hyperglycaemia is a well-known characteristic of type 2 diabetes mellitus and is closely linked to the inflammatory system. Metabolic disorders like diabetes trigger changes in cellular processes and lead to chronic inflammatory disorders. Increased flux through the hexosamine biosynthetic pathway is associated with inflammation, possibly through increased protein O-GlcNAcylation.

CELLS (2022)

Add to Collection

Review Pharmacology & Pharmacy

Changes in Cardiovascular and Renal Biomarkers Associated with SGLT2 Inhibitors Treatment in Patients with Type 2 Diabetes Mellitus

Melpomeni Peppa, Aspasia Manta, Ioanna Mavroeidi, Athina Asimakopoulou, Alexandros Syrigos, Constantinos Nastos, Emmanouil Pikoulis, Anastasios Kollias

Summary: Type 2 diabetes is a global health problem with increasing prevalence. The main concern is the rise in morbidity and mortality due to diabetic complications. Hyperglycemia is considered a major risk factor, and strict glycemic control can have a positive impact on microangiopathy. Sodium-glucose transporter 2 inhibitors are important medications that not only lower blood glucose, but also protect cardiovascular and renal function.

PHARMACEUTICS (2023)

Add to Collection

Article Cell Biology

Rhesus monkeys as a translational model for late-onset Alzheimer's disease

Dylan C. Souder, Isabelle A. Dreischmeier, Alex B. Smith, Samantha Wright, Stephen A. Martin, Md Abdul Kader Sagar, Kevin W. Eliceiri, Shahriar M. Salamat, Barbara B. Bendlin, Ricki J. Colman, T. Mark Beasley, Rozalyn M. Anderson

Summary: Age is a major risk factor for late-onset Alzheimer's disease, and differences in the amyloid plaque microenvironment and the impact of AD pathology on local metabolism and inflammation vary among species, potentially explaining differences in neurodegeneration and functional decline. Using brain tissue from transgenic mice, rhesus monkeys, and human subjects, altered energetics in the plaque microenvironment were observed, highlighting the advantage of nonhuman primates in modeling the disease.

AGING CELL (2021)

Add to Collection

Review Clinical Neurology

Alzheimer's disease biomarkers in Black and non-Hispanic White cohorts: A contextualized review of the evidence

Carey E. Gleason, Megan Zuelsdorff, Diane C. Gooding, Amy J. H. Kind, Adrienne L. Johnson, Taryn T. James, Nickolas H. Lambrou, Mary F. Wyman, Fred B. Ketchum, Alexander Gee, Sterling C. Johnson, Barbara B. Bendlin, Henrik Zetterberg

Summary: This review discusses the disproportionate impact of dementia on Black Americans and examines AD biomarkers using two influential frameworks, NIA-AA and NIA's Health Disparities Research Framework. Recommendations are made to expand studies beyond racial differences, emphasizing the importance of life course experiences and study enrollment practices in explaining observations.

ALZHEIMERS & DEMENTIA (2022)

Add to Collection

Article Neurosciences

Trimethylamine N-Oxide Reduces Neurite Density and Plaque Intensity in a Murine Model of Alzheimer's Disease

Katie R. Zarbock, Jessica H. Han, Ajay P. Singh, Sydney P. Thomas, Barbara B. Bendlin, John M. Denu, John-Paul J. Yu, Federico E. Rey, Tyler K. Ulland

Summary: This study assessed the direct impact of TMAO on AD progression and found that TMAO could affect AD pathology by reducing neurite density.

JOURNAL OF ALZHEIMERS DISEASE (2022)

Add to Collection

Article Neurosciences

Genetic influence on resting state networks in young male and female adults: a cartographer mapping study

Arman P. Kulkarni, Gyujoon Hwang, Cole J. Cook, Rosaleena Mohanty, Akhil Guliani, Veena A. Nair, Barbara B. Bendlin, Elizabeth Meyerand, Vivek Prabhakaran

Summary: In this study, a unique approach based on variance analyses was proposed to investigate the genetic influence on individual differences in brain functional connectivity. The findings suggest that genetic factors play a larger role in brain functional connectivity in males, while environmental factors have a greater impact in females. Moreover, the study reveals that environmental influences on individual differences may outweigh genetic influences in the frontal and overall brain regions.

HUMAN BRAIN MAPPING (2023)

Add to Collection

Article Clinical Neurology

Incidental Findings from 16,400 Brain MRI Examinations of Research Volunteers

P. A. Rowley, M. J. Paukner, L. B. Eisenmenger, A. S. Field, R. J. Davidson, S. C. Johnson, S. Asthana, N. A. Chin, V. Prabhakaran, B. B. Bendlin, B. R. Postle, H. H. Goldsmith, C. M. Carlsson, M. A. Brooks, N. H. Kalin, L. E. Williams, H. A. Rowley

Summary: This study investigated 16,400 brain MRIs and found that incidental findings are common, ranging from trivial to life-threatening. Formal neuroradiologist interpretation yielded more reliable results compared to spontaneous detection by nonradiology scanning staff.

AMERICAN JOURNAL OF NEURORADIOLOGY (2023)

Add to Collection

Article Neurosciences

Cardiorespiratory Fitness Attenuates the Deleterious Effects of Sleep Apnea on Cerebral Structure and Perfusion in the Wisconsin Sleep Cohort Study

Kyle J. Edmunds, Ira Driscoll, Erika W. Hagen, Jodi H. Barnet, Laurel A. Ravelo, David T. Plante, Julian M. Gaitan, Sarah R. Lose, Alice Motovylyak, Barbara B. Bendlin, Ozioma C. Okonkwo, Paul E. Peppard

Summary: This study provides new evidence for the protective role of cardiorespiratory fitness against the deleterious effects of obstructive sleep apnea (OSA) on brain aging.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Add to Collection

Article Clinical Neurology

Neuroimaging of tissue microstructure as a marker of neurodegeneration in the AT(N) framework: defining abnormal neurodegeneration and improving prediction of clinical status

Rigina L. Gallagher, Rebecca Langhough Koscik, Jason F. Moody, Nicholas M. Vogt, Nagesh Adluru, Steven R. Kecskemeti, Carol A. Van Hulle, Nathaniel A. Chin, Sanjay Asthana, Gwendlyn Kollmorgen, Ivonne Suridjan, Cynthia M. Carlsson, Sterling C. Johnson, Douglas C. Dean III, Henrik Zetterberg, Kaj Blennow, Andrew L. Alexander, Barbara B. Bendlin

Summary: This study demonstrates that neurodegeneration-related markers can be detected among cognitively unimpaired individuals, and that these markers can capture early Alzheimer's disease pathology in individuals who are positive for A/T biomarkers but have normal cognitive function.

ALZHEIMERS RESEARCH & THERAPY (2023)

Add to Collection

Article Clinical Neurology

T1-/T2-weighted ratio reveals no alterations to gray matter myelination in temporal lobe epilepsy

Colin Denis, Kevin Dabbs, Veena A. Nair, Jedidiah Mathis, Dace N. Almane, Akshayaa Lakshmanan, Andrew Nencka, Rasmus M. Birn, Lisa Conant, Colin Humphries, Elizabeth Felton, Manoj Raghavan, Edgar A. Deyoe, Jeffrey R. Binder, Bruce Hermann, Vivek Prabhakaran, Barbara B. Bendlin, Mary E. Meyerand, Melanie Boly, Aaron F. Struck

Summary: There were no significant differences in myelin content between patients with temporal lobe epilepsy and the control group.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2023)

Add to Collection

Article Geriatrics & Gerontology

Blazing a trail for the clinical use of rapamycin as a geroprotecTOR

Adam R. Konopka, Dudley W. Lamming

Summary: Rapamycin, an inhibitor of mTORC1, has been shown to extend lifespan and prevent age-related diseases in various model systems. However, concerns over its side effects have limited its translation to humans. Studies suggest that the negative effects of rapamycin are associated with off-target inhibition of mTORC2. Therapeutic windows and alternatives to rapamycin are being explored to achieve more selective inhibition of mTORC1. Ongoing clinical trials aim to address safety, pharmacokinetics, pharmacodynamics, and efficacy of rapamycin and its analogs, providing important information for future phase 3 trials.

GEROSCIENCE (2023)

Add to Collection

Article Geriatrics & Gerontology

Associations between recall of proper names in story recall and CSF amyloid and tau in adults without cognitive impairment

Madeline R. Hale, Rebecca Langhough, Lianlian Du, Bruce P. Hermann, Carol A. Van Hulle, Margherita Carboni, Gwendlyn Kollmorgenj, Kristin E. Basche, Davide Bruno, Leah Sanson-Miles, Erin M. Jonaitis, Nathaniel A. Chin, Ozioma C. Okonkwo, Barbara B. Bendlin, Cynthia M. Carlsson, Henrik Zetterberg, Kaj Blennow, Tobey J. Betthauser, Sterling C. Johnson, Kimberly D. Mueller

Summary: This study demonstrates a relationship between cerebrospinal fluid biomarkers and the ability to recall proper names in the preclinical phase of Alzheimer's disease.

NEUROBIOLOGY OF AGING (2024)

Add to Collection

Article Clinical Neurology

Prevalence and Clinical Implications of a β-Amyloid-Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease

Pontus Erickson, Joel Simren, Wagner S. Brum, Gilda E. Ennis, Gwendlyn Kollmorgen, Ivonne Suridjan, Rebecca Langhough, Erin M. Jonaitis, Carol A. Van Hulle, Tobey J. Betthauser, Cynthia M. Carlsson, Sanjay Asthana, Nicholas J. Ashton, Sterling C. Johnson, Leslie M. Shaw, Kaj Blennow, Ulf Andreasson, Barbara B. Bendlin, Henrik Zetterberg

Summary: The study aims to estimate the prevalence of CSF A-T+ biomarker profile and investigate its clinical implications. The results suggest that A-T+ biomarker profile is found in approximately 5% of lumbar punctures and is not associated with a higher rate of cognitive decline or biomarker signs of disease progression compared with biomarker-negative individuals.

JAMA NEUROLOGY (2023)

Add to Collection

Article Clinical Neurology

Associations between diffusion MRI microstructure and cerebrospinal fluid markers of Alzheimer's disease pathology and neurodegeneration along the Alzheimer's disease continuum

Jason F. Moody, Douglas C. Dean, Steve R. Kecskemeti, Kaj Blennow, Henrik Zetterberg, Gwendlyn Kollmorgen, Ivonne Suridjan, Norbert Wild, Cynthia M. Carlsson, Sterling C. Johnson, Andrew L. Alexander, Barbara B. Bendlin

Summary: This study found widespread white matter injury in AD patients, with robust associations between DWI metrics and AD pathology markers. MAP-MRI had more diffuse relationships with pTau compared to other DWI models. These results suggest that white matter degeneration may be more pervasive in AD and that MAP-MRI could provide clinically viable biomarkers of neurodegeneration in the early stages of AD.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2022)

Add to Collection

Article Clinical Neurology

Crosswalk study on blood collection-tube types for Alzheimer's disease biomarkers

Erin M. Jonaitis, Henrik Zetterberg, Rebecca Langhough Koscik, Tobey J. Betthauser, Carol A. Van Hulle, Kirk Hogan, Laura Hegge, Gwendlyn Kollmorgen, Ivonne Suridjan, Carey E. Gleason, Corinne D. Engelman, Ozioma C. Okonkwo, Sanjay Asthana, Barbara B. Bendlin, Cynthia M. Carlsson, Sterling C. Johnson, Kaj Blennow

Summary: This study investigated the differences in AD blood biomarkers in different collection tube types and found that tube type may cause bias. However, there are correlations between different tube types for some biomarkers, suggesting the potential for harmonization across types.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2022)

Add to Collection

Article Clinical Neurology

Greater tau pathology is associated with altered predictive coding

Klevest Gjini, Cameron Casey, Sean Tanabe, Amber Bo, Margaret Parker, Marissa White, David Kunkel, Richard Lennertz, Robert A. Pearce, Tobey Betthauser, Bradley T. Christian, Sterling C. Johnson, Barbara B. Bendlin, Robert D. Sanders

Summary: Dynamic causal modelling showed that tau pathology is associated with changes in connectivity and excitability of specific brain regions. This affects auditory perception and may be an early indicator of dementia.

BRAIN COMMUNICATIONS (2022)

Add to Collection

Article Clinical Neurology

Asthma amplifies dementia risk: Evidence from CSF biomarkers and cognitive decline

Ajay Kumar Nair, Carol A. Van Hulle, Barbara B. Bendlin, Henrik Zetterberg, Kaj Blennow, Norbert Wild, Gwendlyn Kollmorgen, Ivonne Suridjan, William W. Busse, Melissa A. Rosenkranz

Summary: This study found that severe asthma is associated with synaptic degeneration and may compound the risk for dementia posed by cardiovascular disease and genetic predisposition.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.